Dr. Penke Vijaya Babu is a distinguished chemist with an extensive academic and professional background in pharmaceutical research and development. Holding qualifications such as Ph.D., PDF, MRSC, and MACS, he has made significant contributions to the field of synthetic and analytical chemistry. Dr. Babu is currently the Head RD at Tikvah Pharma Solutions Pvt Ltd in Hyderabad, India, where he leads innovative research initiatives.

His career spans over a decade and includes notable roles at institutions such as Chemridge Laboratories, Curia India Pvt Ltd, Piramal Pharma Solutions, and prestigious postdoctoral fellowships in Israel at Ben-Gurion University of the Negev and The Hebrew University of Jerusalem. Dr. Babu has also held research associate and senior RD chemist positions at several renowned organizations in India, including CSIR, Clearsynth Labs Ltd, and Dr. Reddy's Institute of Life Sciences.

Educationally, Dr. Babu earned his Ph.D. in Chemistry from Jawaharlal Nehru Technological University Hyderabad, with a thesis focused on the design, synthesis, and biological evaluation of heterocycle analogues as anticancer agents. He also holds an M.Sc. in Chemistry and a B.Sc. in Biological and Zoological Chemistry from the same university and Kakatiya University, respectively.

Dr. Babu has been recognized for his contributions through awards such as the Young Scientist Award at the 58th International Academic Achiever Award and the Kreitman Postdoctoral Fellowship. He has authored or co-authored over 150 peer-reviewed articles and holds multiple patents, including a design patent for an automated device for biological samples and analytical detection. His work has been cited over 538 times, with an h-index of 16 and an i10-index of 19.

Professionally, Dr. Babu is an active member of the scientific community, affiliated with the American Chemical Society and the Royal Society of Chemistry. He is also involved in editorial roles for international journals and has expertise in a wide range of analytical and synthetic techniques. His professional responsibilities include process optimization, technology transfer, and adherence to cGMP regulations, contributing to the development of molecules such as Lacosamaide, Apixaban, Linagliptin, and Rivaroxaban.